In Vivo Therapeutic Gas Delivery for Neuroprotection With Echogenic Liposomes

Xenon reduces neurohistopathological damage and improves the early neurological deficit after cardiac arrest in pigs*

(2009) Michael Fries et al.   CRITICAL CARE MEDICINE

Pharmacologic neuroprotection—Is xenon the light at the end of the tunnel?*

(2009) Martin Dworschak   CRITICAL CARE MEDICINE

Nitric Oxide-Loaded Echogenic Liposomes for Nitric Oxide Delivery and Inhibition of Intimal Hyperplasia

(2009) Shao-Ling Huang et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Ultrasound-enhanced thrombolysis with tPA-loaded echogenic liposomes

(2009) George J. Shaw et al.   THROMBOSIS RESEARCH

Tissue Plasminogen Activator (tPA) and Matrix Metalloproteinases in the Pathogenesis of Stroke: Therapeutic Strategies

(2008) Rao Adibhatla et al.   CNS & Neurological Disorders-Drug Targets

Fibrin Targeting of Echogenic Liposomes with Inactivated Tissue Plasminogen Activator

(2008) Melvin E. Klegerman et al.   JOURNAL OF LIPOSOME RESEARCH

NMDA receptors in clinical neurology: excitatory times ahead

(2008) Lorraine V Kalia et al.   LANCET NEUROLOGY

Neuroprotection for ischemic stroke: Past, present and future

(2008) Myron D. Ginsberg   NEUROPHARMACOLOGY

Ultrasound-Enhanced Thrombolysis Using Definity® as a Cavitation Nucleation Agent

(2008) Saurabh Datta et al.   ULTRASOUND IN MEDICINE AND BIOLOGY